These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38360159)

  • 1. "Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World".
    Fernandez Valledor A; Rubinstein G; Moeller CM; Lorenzatti D; Rahman S; Lee C; Oren D; Farrero M; Sayer GT; Uriel N
    J Heart Lung Transplant; 2024 Jun; 43(6):1010-1020. PubMed ID: 38360159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durable left ventricular assist devices as a bridge to transplantation: what to expect along the way?
    Fernandez Valledor A; Moeller CM; Rubinstein G; Oren D; Rahman S; Baranowska J; Lee C; Lorenzatti D; Righini FM; Lotan D; Sayer GT; Uriel N
    Expert Rev Med Devices; 2024 Sep; 21(9):829-840. PubMed ID: 39169616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Use of Left Ventricular Assist Devices as Bridge to Transplantation With New Heart Allocation Policy.
    Mullan CW; Chouairi F; Sen S; Mori M; Clark KAA; Reinhardt SW; Miller PE; Fuery MA; Jacoby D; Maulion C; Anwer M; Geirsson A; Mulligan D; Formica R; Rogers JG; Desai NR; Ahmad T
    JACC Heart Fail; 2021 Jun; 9(6):420-429. PubMed ID: 33714748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of long term left ventricular assist device therapy on donor allocation in cardiac transplantation.
    Uriel N; Jorde UP; Woo Pak S; Jiang J; Clerkin K; Takayama H; Naka Y; Schulze PC; Mancini DM
    J Heart Lung Transplant; 2013 Feb; 32(2):188-95. PubMed ID: 23352392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?
    Wever-Pinzon O; Drakos SG; Kfoury AG; Nativi JN; Gilbert EM; Everitt M; Alharethi R; Brunisholz K; Bader FM; Li DY; Selzman CH; Stehlik J
    Circulation; 2013 Jan; 127(4):452-62. PubMed ID: 23271796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durable mechanical circulatory support as bridge to heart transplantation.
    Badiwala M; Dvirnik N; Rao V
    Curr Opin Organ Transplant; 2022 Oct; 27(5):488-494. PubMed ID: 35950884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.
    Truby LK; Farr MA; Garan AR; Givens R; Restaino SW; Latif F; Takayama H; Naka Y; Takeda K; Topkara VK
    Circulation; 2019 Aug; 140(6):459-469. PubMed ID: 31203669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do Patients Supported With Continuous-flow Left Ventricular Assist Device Have a Sufficient Risk of Death to Justify a Priority Allocation? A Propensity Score Matched Analysis of Patients Listed in UNOS Status 2.
    Mastrobuoni S; Dell'Aquila AM; Van Caenegem O; Poncelet A; Jacquet LM; Garcia J
    Transplantation; 2018 Jun; 102(6):e288-e294. PubMed ID: 29346259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stable patients on left ventricular assist device support have a disproportionate advantage: time to re-evaluate the current UNOS policy.
    Moazami N; Sun B; Feldman D
    J Heart Lung Transplant; 2011 Sep; 30(9):971-4. PubMed ID: 21676630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of the OPTN policy change on patients with a durable left ventricular assist device and chronic kidney disease: Analysis of the UNOS database.
    Warner ED; Pritting C; Dutta S; Bierowski M; Ullah W; Brailovsky Y; Kittleson M; Alvarez RJ; Rame JE; Hajduczok A; Kumar V; Ahmad D; Tchantchaleishvili V; Rajapreyar IN
    Artif Organs; 2024 Oct; 48(10):1180-1189. PubMed ID: 38803277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant.
    Trivedi JR; Cheng A; Singh R; Williams ML; Slaughter MS
    Ann Thorac Surg; 2014 Sep; 98(3):830-4. PubMed ID: 25087934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Year Left Ventricular Assist Device Outcomes and Strategy After Heart Transplant Allocation Score Change.
    Agronin J; Brown M; Calvelli H; Zhao H; Rakita V; Toyoda Y; Kashem MA
    Am J Cardiol; 2024 Sep; 226():1-8. PubMed ID: 38972536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
    Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
    Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporary left ventricular assist devices as a bridge to heart transplantation.
    Seese L; Hickey G; Keebler ME; Mathier MA; Sultan I; Gleason TG; Wang Y; Kilic A
    J Card Surg; 2020 Apr; 35(4):810-817. PubMed ID: 32092194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing Strategy Between Bridge to Transplant and Destination LVAD Therapy After the First 3 Months: Analysis of the STS-INTERMACS Database.
    Rali AS; Inampudi C; Zalawadiya S; Shah A; Teuteberg JJ; Stewart GC; Cantor RS; Deng L; Jacobs JP; Kirklin JK; Stevenson LW
    J Card Fail; 2024 Apr; 30(4):552-561. PubMed ID: 37898382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marginal Improvement in Survival Post-Heart Transplantation in Patients With Prior Left Ventricular Assist Device: A Temporal Analysis of United Network of Organ Sharing Registry.
    Pal N; Stansfield J; Mukhopadhyay N; Nelson M
    J Cardiothorac Vasc Anesth; 2020 Feb; 34(2):392-400. PubMed ID: 31679997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional differences in recipient waitlist time and pre- and post-transplant mortality after the 2006 United Network for Organ Sharing policy changes in the donor heart allocation algorithm.
    Schulze PC; Kitada S; Clerkin K; Jin Z; Mancini DM
    JACC Heart Fail; 2014 Apr; 2(2):166-77. PubMed ID: 24720925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.